In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 26 for your search:
Drug:  sirolimus
Find trials that include:  Any drugs shown
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 1 to under 22 at first relapse
Sponsor: NCI, Other
Protocol IDs: ASCT0431, NCI-2009-01068, CDR0000500131, COG-PBMTC-ONCO51, COG-ASCT0431, U10CA098543, NCT00382109

2.

Phase: Phase III
Type: Supportive care, Treatment
Status: Closed
Age: 2 to 55
Sponsor: NCI, Other
Protocol IDs: 385, U01HL069294, BMT CTN 0402, U01 HL069294-05, NCT00406393

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 72
Sponsor: NCI, Other
Protocol IDs: 09-073, NCT00928018

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257255, P30CA016042, UCLA-0203078, NCI-G02-2114, NCT00047073

5.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000557423, P30CA016042, UCLA-0604104, OSI3781s, NCT00509431

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080078, 08-C-0078, NCT00923273

7.

Phase: Phase II, Phase I
Type: Supportive care
Status: Completed
Age: Per primary treatment protocol
Sponsor: NCI, Other
Protocol IDs: 1811.00, FHCRC-1811.00, CDR0000378004, NCT00089037

8.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 4 to 35
Sponsor: NCI
Protocol IDs: 020259, 02-C-0259, NCI-02-C-0259, NCT00047372, NCT00043979

9.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1938.00, NCI-2010-00268, P30CA015704, P01CA018029, FHCRC-1938.00, 5887, NCT00105001

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 65
Sponsor: NCI, Other
Protocol IDs: CDR0000440080, DFCI-04298, WYETH-C-0468H1-101899, NCT00126672

11.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0507, CDR0000455000, P30CA006973, JHOC-J0507, JHOC-05041402, J0507, NCT00276744

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0415, CDR0000549899, P30CA006973, JHOC-J0415, JHOC-04-06-16-01, J0415, NCT00499486

13.

Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 01089, P30CA033572, CHNMC-01089, CDR0000566376, NCT00544115

14.

Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 2 and over
Sponsor: NCI, Other
Protocol IDs: 06141, P30CA033572, CHNMC-06141, CDR0000579340, NCT00589563

15.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 3 and over
Sponsor: NCI, Other
Protocol IDs: 080096, 08-C-0096, NF-102, NCI-08-C-0096, NCT00652990

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000597130, P30CA022453, WSU-2007-127, GENZ-WSU-2007-127, 2007-127, NCT00691015

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 080151, 08-C-0151, NCI-08-C-0151, NCI-P07252, NCT00722449, NCT00971789

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: NCI, Other
Protocol IDs: 1998.00, FHCRC-1998.00, CDR0000471840, NCT00317785

19.

Phase: Phase II
Type: Supportive care
Status: Completed
Age: Any age
Sponsor: NCI, Other
Protocol IDs: 1706.00, NCI-2011-01817, FHCRC-1706.00, NCT00079183

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 69
Sponsor: NCI, Other
Protocol IDs: CALGB 100701, CDR0000660555, U10CA031946, NCI-2011-01995, NCT01027000

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: JHOC-J0402, CDR0000491204, R21CA112919, P30CA006973, JHOC-J0402, JHOC-04032602, NCT00368914

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000522464, YALE-HIC-26866, N01-CN-25120, NCT00433485

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000536481, U01CA070019, AMC-051, WYETH-0468X-4420, NCT00450320

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 13142A, NCT00707135

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000468942, JHOC-J0576, NCT00311623
1   
New Search